美国医疗保险和医疗补助服务中心(CMS)完成了史上首次大规模药价谈判,针对15种治疗严重慢性病和癌症的药物实现平均降价44%,预计将为医保系统节省120亿美元。这是特朗普政府"平价行动"计划的核心举措,旨在降低医疗和食品成本。 11月26日,据媒体报道,CMS周二宣布,诺和诺德旗下GLP-1类减肥药物Ozempic和Wegovy在此次谈判中降价71%,成为本轮药价谈判中最受关注的成果。此次谈判针对...
Source Link美国医疗保险和医疗补助服务中心(CMS)完成了史上首次大规模药价谈判,针对15种治疗严重慢性病和癌症的药物实现平均降价44%,预计将为医保系统节省120亿美元。这是特朗普政府"平价行动"计划的核心举措,旨在降低医疗和食品成本。 11月26日,据媒体报道,CMS周二宣布,诺和诺德旗下GLP-1类减肥药物Ozempic和Wegovy在此次谈判中降价71%,成为本轮药价谈判中最受关注的成果。此次谈判针对...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.